What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Surgery
His primary areas of study are Hidradenitis suppurativa, Dermatology, Surgery, Internal medicine and Pathology.
The concepts of his Hidradenitis suppurativa study are interwoven with issues in Dermatology Life Quality Index, Adalimumab and Severity of illness.
In general Dermatology study, his work on Atopic dermatitis often relates to the realm of Axilla, thereby connecting several areas of interest.
In his research, Psoriasis is intimately related to Body mass index, which falls under the overarching field of Surgery.
His studies in Internal medicine integrate themes in fields like Placebo and Depression.
He has researched Pathology in several fields, including Optical coherence tomography, Hair follicle and Skin cancer.
His most cited work include:
- Clinical practice. Hidradenitis suppurativa. (473 citations)
- European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa (455 citations)
- The Psychological Burden of Skin Diseases: A Cross-Sectional Multicenter Study among Dermatological Out-Patients in 13 European Countries (335 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Dermatology, Hidradenitis suppurativa, Internal medicine, Pathology and Surgery.
In his study, Clinical trial is strongly linked to Randomized controlled trial, which falls under the umbrella field of Dermatology.
His Hidradenitis suppurativa research includes elements of Cross-sectional study, Severity of illness and Quality of life.
His Quality of life research incorporates elements of Physical therapy and Depression.
His Internal medicine study frequently draws connections to other fields, such as Endocrinology.
Gregor B.E. Jemec works mostly in the field of Pathology, limiting it down to topics relating to Optical coherence tomography and, in certain cases, Skin cancer, Basal cell carcinoma, Actinic keratosis, Biomedical engineering and In vivo, as a part of the same area of interest.
He most often published in these fields:
- Dermatology (43.64%)
- Hidradenitis suppurativa (33.64%)
- Internal medicine (13.94%)
What were the highlights of his more recent work (between 2018-2021)?
- Hidradenitis suppurativa (33.64%)
- Dermatology (43.64%)
- Internal medicine (13.94%)
In recent papers he was focusing on the following fields of study:
Hidradenitis suppurativa, Dermatology, Internal medicine, Disease and Acne are his primary areas of study.
His study in Hidradenitis suppurativa is interdisciplinary in nature, drawing from both Body mass index, Cross-sectional study, Quality of life, Intertriginous and Depression.
His Dermatology study combines topics from a wide range of disciplines, such as Groin and Clinical trial.
His work in Internal medicine covers topics such as Clindamycin which are related to areas like Combination therapy.
His Disease study combines topics in areas such as Obesity, Family medicine, Tinea capitis, Painful skin and Family history.
Gregor B.E. Jemec has included themes like Severity of illness and Venereology in his Acne study.
Between 2018 and 2021, his most popular works were:
- Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study. (61 citations)
- Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization – systematic review and recommendations from the HS ALLIANCE working group (54 citations)
- Long-term efficacy of novel therapies in moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis of PASI response. (37 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Surgery
Gregor B.E. Jemec spends much of his time researching Hidradenitis suppurativa, Dermatology, Internal medicine, Disease and Quality of life.
His Hidradenitis suppurativa research is multidisciplinary, incorporating perspectives in Adalimumab, Acne, Randomized controlled trial, Intertriginous and Metagenomics.
Dermatology is often connected to Clinical trial in his work.
His Disease research is multidisciplinary, incorporating elements of Emergency department, Mood disorders and Family medicine.
His work deals with themes such as Depression and Anxiety, which intersect with Quality of life.
His research investigates the connection between Odds ratio and topics such as Confidence interval that intersect with problems in Cross-sectional study, Body mass index and Cohort.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
